SNAI2 and hepatocellular carcinoma: (26) demonstrated that the lncRNA HOXA11−AS acts as an oncogene to promote the proliferation, invasion, and metastasis of hepatocellular carcinoma cells and epithelial-mesenchymal transition through the miR-506-3p/Slug axis, which provides a new therapeutic target for hepatocellular carcinoma patients.